1 asset in Intestinal Motility Disease
Therapeutic assets addressing Intestinal Motility Disease, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Rifaximin Intestinal Motility Disease | MetroHealth Medical Center | P3 | B (59) |